By the way, Zhittya Genesis Medicine in their Update also reports the development of intranasal delivery of their products. Is this something we should Venturis should be looking into?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.